Global Artificial Bioactive Bone 麻豆原创 Research Report 2025

Publication ID:

PB503254211

Publication Date:

March 7, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Retailing [2]

Consumer & Retail [3]

Description:

The global market for Artificial Bioactive Bone was valued at US$ 1052 million in the year 2024 and is projected to reach a revised size of US$ 1625 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Artificial bioactive bone is a bone-like material created in laboratory that can be used in bone grafts to replace human bone that was lost due to severe fractures or bone and joint diseases. Artificial bones are made from using materials such as ceramics, composite, polymer, hydroxyapatite, and others. Artificial bones are mostly used for the surgeries of spinal fusion, dental therapies, craniomaxillofacial surgery, joint reconstruction, and extremities.
Global 5 largest manufacturers of Artificial Bioactive Bone are Baxter International, Stryker Corporation, Geistlich Pharma, Dentsply Sirona and Medtronic, which make up over 50%. Among them, Baxter International is the leader with about 17% market share. North America is the largest market, with a share about 52%, followed by Europe and China, with the share about 24% and 9%. In terms of product type, Ceramics occupy the largest share of the total market, about 78%. And in terms of product Application, the largest application is Orthopaedic, followed by Dental.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Bioactive Bone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Bioactive Bone.
The Artificial Bioactive Bone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Bioactive Bone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Bioactive Bone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Stryker Corporation
Zimmer Biomet
Medtronic
Johnson & Johnson
Baxter International
ZimVie
NuVasive
Orthofix
Surgalign
Globus Medical
Bioventus
Geistlich Pharma
Dentsply Sirona
Curasan
Advanced Medical Solutions
Segment by Type
Ceramics
Composite Material
Bioactive Glass
Polymer and Other
Segment by Application
Orthopaedic
Dental
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Bioactive Bone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Bioactive Bone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Artificial Bioactive Bone 麻豆原创 Overview
1.1 Product Definition
1.2 Artificial Bioactive Bone by Type
1.2.1 Global Artificial Bioactive Bone 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Ceramics
1.2.3 Composite Material
1.2.4 Bioactive Glass
1.2.5 Polymer and Other
1.3 Artificial Bioactive Bone by Application
1.3.1 Global Artificial Bioactive Bone 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Orthopaedic
1.3.3 Dental
1.4 Global Artificial Bioactive Bone 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Artificial Bioactive Bone Revenue 2020-2031
1.4.2 Global Artificial Bioactive Bone Sales 2020-2031
1.4.3 Global Artificial Bioactive Bone 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Artificial Bioactive Bone 麻豆原创 Competition by Manufacturers
2.1 Global Artificial Bioactive Bone Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Artificial Bioactive Bone Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Artificial Bioactive Bone Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Artificial Bioactive Bone, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Bioactive Bone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Bioactive Bone, Product Type & Application
2.7 Global Key Manufacturers of Artificial Bioactive Bone, Date of Enter into This Industry
2.8 Global Artificial Bioactive Bone 麻豆原创 Competitive Situation and Trends
2.8.1 Global Artificial Bioactive Bone 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Artificial Bioactive Bone Players 麻豆原创 Share by Revenue
2.8.3 Global Artificial Bioactive Bone 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Artificial Bioactive Bone 麻豆原创 Scenario by Region
3.1 Global Artificial Bioactive Bone 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Artificial Bioactive Bone Sales by Region: 2020-2031
3.2.1 Global Artificial Bioactive Bone Sales by Region: 2020-2025
3.2.2 Global Artificial Bioactive Bone Sales by Region: 2026-2031
3.3 Global Artificial Bioactive Bone Revenue by Region: 2020-2031
3.3.1 Global Artificial Bioactive Bone Revenue by Region: 2020-2025
3.3.2 Global Artificial Bioactive Bone Revenue by Region: 2026-2031
3.4 North America Artificial Bioactive Bone 麻豆原创 Facts & Figures by Country
3.4.1 North America Artificial Bioactive Bone 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Artificial Bioactive Bone Sales by Country (2020-2031)
3.4.3 North America Artificial Bioactive Bone Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Artificial Bioactive Bone 麻豆原创 Facts & Figures by Country
3.5.1 Europe Artificial Bioactive Bone 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Artificial Bioactive Bone Sales by Country (2020-2031)
3.5.3 Europe Artificial Bioactive Bone Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Bioactive Bone 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Artificial Bioactive Bone 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Artificial Bioactive Bone Sales by Region (2020-2031)
3.6.3 Asia Pacific Artificial Bioactive Bone Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Artificial Bioactive Bone 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Artificial Bioactive Bone 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Artificial Bioactive Bone Sales by Country (2020-2031)
3.7.3 Latin America Artificial Bioactive Bone Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Bioactive Bone 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Bioactive Bone 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Artificial Bioactive Bone Sales by Country (2020-2031)
3.8.3 Middle East and Africa Artificial Bioactive Bone Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Bioactive Bone Sales by Type (2020-2031)
4.1.1 Global Artificial Bioactive Bone Sales by Type (2020-2025)
4.1.2 Global Artificial Bioactive Bone Sales by Type (2026-2031)
4.1.3 Global Artificial Bioactive Bone Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Artificial Bioactive Bone Revenue by Type (2020-2031)
4.2.1 Global Artificial Bioactive Bone Revenue by Type (2020-2025)
4.2.2 Global Artificial Bioactive Bone Revenue by Type (2026-2031)
4.2.3 Global Artificial Bioactive Bone Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Artificial Bioactive Bone Price by Type (2020-2031)
5 Segment by Application
5.1 Global Artificial Bioactive Bone Sales by Application (2020-2031)
5.1.1 Global Artificial Bioactive Bone Sales by Application (2020-2025)
5.1.2 Global Artificial Bioactive Bone Sales by Application (2026-2031)
5.1.3 Global Artificial Bioactive Bone Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Artificial Bioactive Bone Revenue by Application (2020-2031)
5.2.1 Global Artificial Bioactive Bone Revenue by Application (2020-2025)
5.2.2 Global Artificial Bioactive Bone Revenue by Application (2026-2031)
5.2.3 Global Artificial Bioactive Bone Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Artificial Bioactive Bone Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Stryker Corporation
6.1.1 Stryker Corporation Company Information
6.1.2 Stryker Corporation Description and Business Overview
6.1.3 Stryker Corporation Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Stryker Corporation Artificial Bioactive Bone Product Portfolio
6.1.5 Stryker Corporation Recent Developments/Updates
6.2 Zimmer Biomet
6.2.1 Zimmer Biomet Company Information
6.2.2 Zimmer Biomet Description and Business Overview
6.2.3 Zimmer Biomet Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zimmer Biomet Artificial Bioactive Bone Product Portfolio
6.2.5 Zimmer Biomet Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medtronic Artificial Bioactive Bone Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Artificial Bioactive Bone Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Baxter International
6.5.1 Baxter International Company Information
6.5.2 Baxter International Description and Business Overview
6.5.3 Baxter International Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Baxter International Artificial Bioactive Bone Product Portfolio
6.5.5 Baxter International Recent Developments/Updates
6.6 ZimVie
6.6.1 ZimVie Company Information
6.6.2 ZimVie Description and Business Overview
6.6.3 ZimVie Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ZimVie Artificial Bioactive Bone Product Portfolio
6.6.5 ZimVie Recent Developments/Updates
6.7 NuVasive
6.7.1 NuVasive Company Information
6.7.2 NuVasive Description and Business Overview
6.7.3 NuVasive Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NuVasive Artificial Bioactive Bone Product Portfolio
6.7.5 NuVasive Recent Developments/Updates
6.8 Orthofix
6.8.1 Orthofix Company Information
6.8.2 Orthofix Description and Business Overview
6.8.3 Orthofix Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Orthofix Artificial Bioactive Bone Product Portfolio
6.8.5 Orthofix Recent Developments/Updates
6.9 Surgalign
6.9.1 Surgalign Company Information
6.9.2 Surgalign Description and Business Overview
6.9.3 Surgalign Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Surgalign Artificial Bioactive Bone Product Portfolio
6.9.5 Surgalign Recent Developments/Updates
6.10 Globus Medical
6.10.1 Globus Medical Company Information
6.10.2 Globus Medical Description and Business Overview
6.10.3 Globus Medical Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Globus Medical Artificial Bioactive Bone Product Portfolio
6.10.5 Globus Medical Recent Developments/Updates
6.11 Bioventus
6.11.1 Bioventus Company Information
6.11.2 Bioventus Description and Business Overview
6.11.3 Bioventus Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bioventus Artificial Bioactive Bone Product Portfolio
6.11.5 Bioventus Recent Developments/Updates
6.12 Geistlich Pharma
6.12.1 Geistlich Pharma Company Information
6.12.2 Geistlich Pharma Description and Business Overview
6.12.3 Geistlich Pharma Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Geistlich Pharma Artificial Bioactive Bone Product Portfolio
6.12.5 Geistlich Pharma Recent Developments/Updates
6.13 Dentsply Sirona
6.13.1 Dentsply Sirona Company Information
6.13.2 Dentsply Sirona Description and Business Overview
6.13.3 Dentsply Sirona Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dentsply Sirona Artificial Bioactive Bone Product Portfolio
6.13.5 Dentsply Sirona Recent Developments/Updates
6.14 Curasan
6.14.1 Curasan Company Information
6.14.2 Curasan Description and Business Overview
6.14.3 Curasan Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Curasan Artificial Bioactive Bone Product Portfolio
6.14.5 Curasan Recent Developments/Updates
6.15 Advanced Medical Solutions
6.15.1 Advanced Medical Solutions Company Information
6.15.2 Advanced Medical Solutions Description and Business Overview
6.15.3 Advanced Medical Solutions Artificial Bioactive Bone Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Advanced Medical Solutions Artificial Bioactive Bone Product Portfolio
6.15.5 Advanced Medical Solutions Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Bioactive Bone Industry Chain Analysis
7.2 Artificial Bioactive Bone Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Bioactive Bone Production Mode & Process Analysis
7.4 Artificial Bioactive Bone Sales and 麻豆原创ing
7.4.1 Artificial Bioactive Bone Sales Channels
7.4.2 Artificial Bioactive Bone Distributors
7.5 Artificial Bioactive Bone Customer Analysis
8 Artificial Bioactive Bone 麻豆原创 Dynamics
8.1 Artificial Bioactive Bone Industry Trends
8.2 Artificial Bioactive Bone 麻豆原创 Drivers
8.3 Artificial Bioactive Bone 麻豆原创 Challenges
8.4 Artificial Bioactive Bone 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Stryker Corporation
Zimmer Biomet
Medtronic
Johnson & Johnson
Baxter International
ZimVie
NuVasive
Orthofix
Surgalign
Globus Medical
Bioventus
Geistlich Pharma
Dentsply Sirona
Curasan
Advanced Medical Solutions

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.